Avantax Planning Partners’s Heron Therapeutics HRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-122	Closed	-$4K	–	682
2018 Q3	$4K	Buy	+122	New	+$4K	﹤0.01%	1165
2018 Q2	–	Sell	-160	Closed	-$4K	–	762
2018 Q1	$4K	Buy	+160	New	+$4K	﹤0.01%	1417